frequent type of PTL, is classified as mucosa-associated lymphoid tissue (MALT) lymphoma, diffuse large B-cell lymphoma (DLCBL), and mixed type (5) . In addition, it has histological subtypes that are less frequent such as follicular lymphoma, small lymphocytic lymphoma, Burkitt's lymphoma of the thyroid, primary thyroid mantle cell lymphoma, and primary thyroid T-cell lymphoma (6) (7) (8) (9) (10) .
Fine needle aspirate (FNA) biopsy is frequently used to diagnose the disease, but is not always successful (11) . Therefore, core needle biopsy or surgical biopsy is used in such cases (12, 13) . PTLs are typically sensitive to chemotherapy and radiotherapy and, hence, the role of surgery in treatment is restricted. The five-year survival rate of a PTL patient that is accurately diagnosed and treated is stated to be 90% (12) . Therefore, accurate diagnosis and rapid targeted treatment are vital in these PTL cases. In this study, clinical and histopathological features of 11 patients with PTL were evaluated in terms of the means of preparative diagnosis and postoperative follow-up data.
Results

Patient demographics
The median age of the 11 patients examined in this study was 61 years (range: 15-76 years). Six were female (54.5%), five were male (45.5%), and the female/male ratio was 1.2. The median age of females was 60 years (range: 36-76 years), and the median age of males was 54 years (range: 15-65 years). In our institute, the prevalence of PTL is about 3.5%. The mean follow-up period of the patients was 34 months (range: 19-70 months). Although all patients had a large palpable swelling in the neck, only five patients (45.5%) had symptoms of compression. One patient (9.1%) had type B symptoms, including fever, night sweats, and weight loss. Although FNA biopsy was performed in all patients, only 7 (63.6%) could be diagnosed as having PTL. Two patients (18.2%) were diagnosed by excisional biopsy, and 2 (18.2%) were diagnosed by surgical excision (Table 1 ). All patients were euthyroid.
Histopathologic evaluation and staging of the patients
Histopathologic evaluation revealed DLBCL [n = 9 (81.8%)], and two other patients had MALT lymphoma (18.2%). Five (45.5%) were at Stage IE, 4 (36.4%) were at IIE, 1 (9.1%) was at IIIE, and 1 (9.1%) was at IVE (Table 1) .
Evaluation of research parameters
Ultrasonographic examination of the masses revealed that lesions were hypoechoic for 6 (54.5%) patients and isoechoic for 5 (45.5%) ( Table 1) .
Seven (63.6%) patients received only chemotherapy. On the other hand, four (36.4%) underwent both chemotherapy and radiotherapy. Average length followup of the patients was 34 months. Only one patient (9.1%) with histologic subtype DLBCL had recurrence, observed after a 20-month follow-up period ( Table 1) .
The clinical and radiologic features of the patients are summarized in Table 2 . Five (55.6%) of the nine patients with DLBCL were female and four (44.4%) were male. All patients had a large palpable swelling in the neck. Furthermore, three patients (33.3%) had dyspnea, one patient (11.1%) had dysphonia, and one patient (11.1%) had both dyspnea and dysphonia as associated symptoms. Three patients (33.3%) with DLBCL had a history of Hashimoto's thyroiditis.
Two patients (one female, 50%) with a histologic subtype of MALT lymphoma presented with cervical mass as the primary complaint. One female (50% of the patients) had Hashimoto's thyroiditis history. Biopsy was used for definitive diagnosis in both, and the stages of the disease in these patients were Stages IE and IIE, respectively. MALT lymphoma lesions appeared to be hypoechoic on the ultrasonographic examination. One patient (50%) received chemotherapy as the primary therapy. On the other hand, the other patient (50%) received a combination of chemotherapy and radiotherapy. During the median follow-up period, recurrence did not develop in these patients.
4
. Discussion PTL is a rare disease entity that is frequently seen in females with chronic Hashimoto's thyroiditis (16) . PTL is seen to occur on average between the ages of 59 and 71 years (16) . Its female/male ratio is 3-4/1, and it has been reported to appear 10 years earlier in men than in women (3, 6, 17) . Females constituted 54.5% of all patients in our study, and female/male ratio was 6/5. This female dominance can be due to autoimmune thyroid diseases occurring more commonly in women. It is thought that there may be a link between PTL and Hashimoto's thyroiditis (lymphocytic thyroiditis). The risk for PTL is increased by 67%-80% in patients with Hashimoto's thyroiditis (18, 19) . Our study has indicated that Hashimoto's thyroiditis is commonly associated with PTL.
The most frequent symptoms are dyspnea and hoarseness, related to the large palpable mass in the neck leading to compression symptoms and/or infiltration of the surrounding neck tissues (16, 20) . In 10% of patients, type B symptoms can be seen such as fever, night sweat, and weight loss (21) . Symptoms of hypothyroidism can be seen at a rate of 10%; however, most patients are reported to be euthyroid (22) . In our study, the clinical symptoms of the patients were similar to those in the literature.
Ultrasonography is usually the first imaging modality performed of a thyroid mass. PTL generally appears as heterogeneous, intense hypoechoic areas, but these findings are not specific (23), since they overlap with anaplastic thyroid cancer. Furthermore, the diagnostic accuracy of imaging methods, such as computerized tomography, MR, and scintigraphy, is low. In this study, the radiologic findings were similar to other study results (24, 25) .
After imaging, the next diagnostic step accepted for most thyroid masses is FNA biopsy. Although the sensitivity of FNA biopsy for definitive diagnosis was low in previous years due to certain limitations, the value of FNA biopsy has increased in recent years, thanks to the advances in immunohistochemical and flow cytometric methods. However, an expert pathologist is needed for the diagnosis of PTL with FNA biopsy, and it is absolutely necessary to share with the pathologist that there may be a PTL, because the ability of FNA biopsy in differentiating between Hashimoto's thyroiditis and PTL is unreliable (25, 26) . Furthermore, differentiation between undifferentiated thyroid carcinomas and PTL cannot always be made by FNA biopsy, due to the existence of low-grade malignancy. In the study by Matzuka et al. involving 119 patients, it Follow-up period (months) 34 was reported that the diagnoses of 78% of patients were confirmed with FNA biopsy (27 (22) . The study by Sharma et al. suggested core needle biopsy as the first diagnostic step when thyroid lymphoma is suspected (23) . However, we selected excisional biopsy, because it provides clearer histopathological information and shows the exact degree of malignancy. In addition, this would likely decrease the repeat biopsy interventions. In the last three decades, the role of surgery in thyroid lymphomas has changed. While previously, surgery was thought to be the primary treatment, today the primary treatments are chemotherapy and radiotherapy (28) (29) (30) . Despite this regression of surgical treatment, 61% of patients with thyroid lymphoma are reported to have undergone surgery for various reasons between 1997 and 2005, according to the SEER database analysis (6) . Due to providing quick decompression in MALT lymphoma, in patients with thyroid-localized diseases or lifethreatening compression symptoms, surgical treatment is still performed today (3, 9, (31) (32) (33) (34) . In fact, according to the SEER database analysis, the long-term results of patients treated only with surgery or with surgery and radiotherapy are reported to be better than those treated only with chemotherapy (6). In our study, a thyroidectomy was performed in one patient, whose FNA biopsy diagnosis was reported as suspicious for anaplastic carcinoma. Histopathologic type and stage are the most important factors that determine prognosis for PTL patients. DLBCL is more aggressive than MALT lymphoma, and according to other studies, the five-year disease survival rate is approximately 75% (3, 9, 32) . MALT lymphoma is frequently restricted to the thyroid and is determined at an early stage (5). Disease-specific survival rate is 96% (3, 6) . The mixed type has a similar clinical course to DLBCL (12) . Stage is one of the factors that affects PTL prognosis. Generally, as the stage progresses, the possibility of survival decreases.
According to a population-based study, five-year survival rate is 86% at Stage IE, 81% at Stage IIE, and decreases to 64% at Stages IIIE and IVE (12) . In this study, 9 patients (81.8%) are at Stages IE and IIE. Recurrence occurred in one patient (9.1%), who was at Stage IIIE.
Thyroid lymphomas are tumors that are responsive to radiotherapy and chemotherapy; these should be given prior consideration in primary treatment. If the tumor is localized to the thyroid gland, external beam radiation can be preferred for primary treatment. Response to radiotherapy is dramatic and enables quick shrinkage of the tumor. However, relapses have been reported in about 30% of patients, even if the disease was at Stage IE or IIE (29) . For this reason, the dominant view is that even if it appears to be a localized disease, there is a need for combination chemotherapy regimens. Chemotherapy is used as a primary treatment in advanced diseases or in combination with radiotherapy in localized diseases. The combination chemotherapy regimen usually consists of CHOP and R-CHOP. Rituximab is a monoclonal antibody that selectively binds to the CD20 antigen found on the surface of pre-B and mature B lymphocytes (35) . Meta-analysis of published reports on primary nodal lymphoma patients verifies the superiority of adding rituximab to combination chemotherapy (36) . Several other monoclonal antibody drugs are entering clinical practice (e.g., obinutuzumab, ofatumumab, and ibritumomab) (37) . In our study, 5 patients with DLBCL received R-CHOP chemotherapy regimen, and 1 received only CHOP regimen therapy. One patient with MALT lymphoma received R-CHOP chemotherapy regimen. Prospective randomized studies are still needed to determine the best method of diagnosis and treatment. However, the fact that it is a very rare disease and that the number of patients is limited makes it almost impossible for such studies to be conducted.
In conclusion, PTL is a disease with good prognosis after treatment, performed according to whether it is limited to the thyroid gland, low grade, Stage IE, or according to its histological type. PTL is very similar to anaplastic thyroid carcinomas in terms of symptoms. Therefore, rapid accurate diagnosis and initiation of prompt therapy are important. The FNA biopsy can be used initially; however, if pathologic diagnosis is suspicious and PTL diagnosis is supported by clinical features, other diagnostic tools can be used. Creating a standardized diagnosis protocol and effective treatment modality for PTL requires further studies with a larger number of patients.
